TESAMORELIN — 20 MG

Description

DESCRIPTION

Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH). It is studied in research models for binding at the GHRH receptor and downstream GH axis signaling.

RESEARCH AREAS

• GHRH receptor agonism — studied in cell-based assays for receptor binding and cAMP signaling.
• Pituitary GH release — investigated in preclinical models for GH axis stimulation.
• Stability characterization — research has documented its extended half-life relative to native GHRH.
• Adipocyte research — investigated in cell culture for lipid metabolism signaling.

WHAT RESEARCHERS LOOK AT

• Mechanism: GHRH receptor agonism and downstream IGF-1 pathway research.
• Stability and structural modifications relative to native GHRH.
• Applications in pituitary and metabolic research models.
• Comparative profiling alongside other GHRH analog research compounds.

QUICK SPECS

• Form: Lyophilized peptide
• Net per vial: 20 mg
• Purity: ≥99% (HPLC)
• Identity: MS-verified (per COA)
• Storage: 2–8 °C, protect from light

IDENTITY BASICS

• Type: GHRH receptor agonist (44-amino-acid analog)
• Formula / M.W.: Peptide analog (~5135.9 g/mol)
• CAS: 218949-48-5

SELECTED RESEARCH

• PubChem entry — chemical identity:
  https://pubchem.ncbi.nlm.nih.gov/compound/16139605
• GHRH receptor pharmacology research:
  https://pubmed.ncbi.nlm.nih.gov/

⚠️ DISCLAIMER

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.